Related Experiment Video

Updated: Aug 14, 2026

Paradigms for Pharmacological Characterization of C. elegans Synaptic Transmission Mutants
18:01

Paradigms for Pharmacological Characterization of C. elegans Synaptic Transmission Mutants

Published on: August 18, 2008

Muscimol as an antagonist of chemical convulsants

W E Stone, M J Javid

    Archives Internationales De Pharmacodynamie Et De Therapie
    |October 1, 1981
    PubMed

    Insights

    Muscimol demonstrates anticonvulsant effects in mice, particularly against 3-mercaptopropionic acid-induced seizures. Its action profile supports its role as a GABA agonist, offering insights into seizure mechanisms.

    Area of Science:

    • Neuropharmacology
    • GABAergic system research

    Background:

    • GABAergic system dysfunction is implicated in various seizure disorders.
    • Understanding the mechanisms of anticonvulsant drugs is crucial for developing effective epilepsy treatments.

    Purpose of the Study:

    • To evaluate the anticonvulsant properties of Muscimol (MU) against chemically induced seizures in mice.
    • To compare the action profile of MU with other known anticonvulsants and GABAergic agents.

    Main Methods:

    • Administration of Muscimol (1.5 mg/kg) to mice.
    • Induction of seizures using chemical convulsants: 3-mercaptopropionic acid (3-MP), pentylenetretrazol (PTZ), bicuculline (BIC), picrotoxin (PIC), kainic acid, and aminophylline.
    • Assessment of Muscimol's inhibitory and potentiating effects on seizure induction.

    Main Results:

    • Muscimol exhibited significant anticonvulsant activity against 3-mercaptopropionic acid-induced seizures.
    • Muscimol showed greater sensitivity to inhibition by MU compared to pentylenetretrazol or bicuculline.
    • Picrotoxin and kainic acid-induced seizures were not antagonized by Muscimol; aminophylline-induced seizures were potentiated.
    • The action profile of Muscimol closely resembled that of aminooxyacetic acid (AOAA), with key differences in kainic acid antagonism.

    Conclusions:

    • The findings support the hypothesis that Muscimol acts as a GABA agonist.
    • GABA antagonism alone may not fully explain the convulsant actions of bicuculline or picrotoxin.
    • Aminooxyacetic acid's antagonism of kainic acid-induced seizures might involve mechanisms beyond the GABA system.

    More Related Videos

    Subcutaneous Administration of Muscarinic Antagonists and Triple-Immunostaining of the Levator Auris Longus Muscle in Mice07:09

    Subcutaneous Administration of Muscarinic Antagonists and Triple-Immunostaining of the Levator Auris Longus Muscle in Mice

    Published on: September 8, 2011

    Stimulated Single Fiber Electromyography (SFEMG) for Assessing Neuromuscular Junction Transmission in Rodent Models04:30

    Stimulated Single Fiber Electromyography (SFEMG) for Assessing Neuromuscular Junction Transmission in Rodent Models

    Published on: March 8, 2024

    Related Concept Videos

    Cholinergic Antagonists: Chemistry and Structure-Activity Relationship01:29

    Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

    Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic antagonists are called...
    Cholinergic Antagonists: Pharmacological Actions01:28

    Cholinergic Antagonists: Pharmacological Actions

    Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
    Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
    Classification of Skeletal Muscle Relaxants01:28

    Classification of Skeletal Muscle Relaxants

    Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
    Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
    Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action01:17

    Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

    Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
    Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
    Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions01:27

    Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

    Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
    Although all competitive neuromuscular blockers are designed...
    Spasmolytic Agents: Chemical Classification01:29

    Spasmolytic Agents: Chemical Classification

    Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
    A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also promote...